Jinsuk Kanga, Matthias Lienharda,b, William A. Pastora,1, Ashu Chawlaa, Mark Novotnyc, Ageliki Tsagaratoua, Roger S. Laskenc, Elizabeth C. Thompsona,2, M. Azim Suranid, Sergei B. Koralove, Sundeep Kalantryf, Lukas Chaveza,3,4, and Anjana Raoa,g,h,i,4
aDivision of Signaling and Gene Expression, La Jolla Institute for Allergy and Immunology, CA 92037;
bMax Planck Institute for Molecular Genetics, 14195 Berlin, Germany;
cJ. Craig Venter Institute, La Jolla, CA 92037;
dWellcome Trust Cancer Research UK Gurdon Institute, University of Cambridge, Cambridge CB2 1QN, United Kingdom;
eDepartment of Pathology, New York University School of Medicine, New York, NY 10016;
fDepartment of Human Genetics, University of Michigan, Ann Arbor, MI 48109;
gDepartment of Pharmacology, University of California at San Diego, La Jolla, CA 92093;
hMoores Cancer Center, University of California at San Diego, La Jolla, CA 92093;
iSanford Consortium for Regenerative Medicine, La Jolla, CA 92037
Abstract
Dioxygenases of the TET (Ten-Eleven Translocation) family produce oxidized methylcytosines, intermediates in DNA demethylation, as well as new epigenetic marks. Here we show data suggesting that TET proteins maintain the consistency of gene transcription. Embryos lacking Tet1 and Tet3 (Tet1/3 DKO) displayed a strong loss of 5-hydroxymethylcytosine (5hmC) and a concurrent increase in 5-methylcytosine (5mC) at the eight-cell stage. Single cells from eight-cell embryos and individual embryonic day 3.5 blastocysts showed unexpectedly variable gene expression compared with controls, and this variability correlated in blastocysts with variably increased 5mC/5hmC in gene bodies and repetitive elements. Despite the variability, genes encoding regulators of cholesterol biosynthesis were reproducibly down-regulated in Tet1/3 DKO blastocysts, resulting in a characteristic phenotype of holoprosencephaly in the few embryos that survived to later stages. Thus, TET enzymes and DNA cytosine modifications could directly or indirectly modulate transcriptional noise, resulting in the selective susceptibility of certain intracellular pathways to regulation by TET proteins.
DNA methylation, cholesterol biosynthesis, TET methylcytosine oxidases, 5-hydroxymethylcytosine, 5hmC
1Present address: Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, CA 90095.
2Present address: Immunity, Cell Press, Cambridge, MA 02139.
3Present address: Division of Pediatric Neurooncology, Group Leader Computational Oncoepigenomics, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.
4To whom correspondence may be addressed.
Author contributions: J.K., M.A.S., S.K., and A.R. designed research; J.K. performed research; J.K., W.A.P., M.N., A.T., R.S.L., E.C.T., and S.B.K. contributed new reagents/analytic tools; J.K., M.L., A.C., and L.C. analyzed data; and J.K. and A.R. wrote the paper.